Abraxane and blood glucose increased Patient Reports February 11, 2012

Abraxane Side Effects Report #5573590-3
Abraxane side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2007. Female patient, 83 years of age, weighting 150.5 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: arrhythmia , asthenia, blood culture positive, blood glucose increased, blood urea increased, cardiac failure congestive, confusional state, dehydration, diarrhoea. Abraxane dosage: 216 MG DAY EVERY 21 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CAPECITABINE, ALTACE, HYDROCHLOROTHIAZIDE, TRICOR, HUMULIN, AMBIEN, DILAUDID, LEVOXYL. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5091565-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Female patient, 66 years of age, weighting 163.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, aspartate aminotransferase increased, asthenia, blood albumin decreased, blood bilirubin increased, blood glucose increased, disease progression, fatigue, liver function test abnormal. Abraxane dosage: 470 MG ONCE (260 MG/M2,X1), INTRAVENOUS DRIP. During the same period patient was treated with VICODIN, XELODA, EFFEXOR, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient died on 03/26/2006.

Abraxane Side Effects Report #5108520-1
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2006. Female patient, 66 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, blood albumin decreased, blood glucose increased, disease progression, mucosal inflammation, oral candidiasis, pancytopenia, sepsis . Abraxane dosage: 470 MG ONCE (260 MG/M2, X 1). During the same period patient was treated with VICODIN, XELODA, VENLAFAXINE, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient died.

Abraxane Side Effects Report #4820665-X
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 14, 2005. Female patient, 66 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alpha haemolytic streptococcal infection, aspartate aminotransferase increased, asthenia, blood albumin decreased, blood bilirubin increased, blood culture positive, blood glucose increased, fatigue. Abraxane dosage: 470 MG (260 MG/M2 EVERY 3 WEEKS). During the same period patient was treated with VICODIN, XELODA, EFFEXOR, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #4820962-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 14, 2005. Female patient, 66 years of age, weighting 163.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: albumin globulin ratio decreased, aspartate aminotransferase increased, asthenia, blood albumin decreased, blood bilirubin increased, blood glucose increased, candidiasis, fatigue, globulins decreased. Abraxane dosage: 470 MG (20 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with VICODIN, XELODA, EFFEXOR, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5286063-2
Abraxane side effect was reported by a Physician from UNITED STATES on Mar 17, 2007. Female patient, 63 years of age, weighting 170.9 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood glucose increased, condition aggravated, disease progression, facial palsy, herpes simplex , neuropathy peripheral. Abraxane dosage: 400 MG DAY/EVERY 3 WEEKS 8 DOSES (220 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with HORMONAL AGENTS, FENTANYL PATCH, LIPITOR, PRILOSEC, ACCUPRIL, ZOMETA, GLUCOPHAGE, GLYBURIDE. Patient recovered.

Abraxane Side Effects Report #5302524-1
Abraxane side effect was reported by a Physician from UNITED STATES on Mar 29, 2007. Female patient, 63 years of age, weighting 170.9 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood glucose increased, condition aggravated, disease progression, facial palsy, herpes simplex , neuropathy peripheral. Abraxane dosage: 400 MG DAY/EVERY 3 WEEKS 8 DOSES (220 MG/M2,EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with HORMONAL AGENTS, FENTANYL PATCH, LIPITOR, PRILOSEC, ACCUPRIL, ZOMETA, GLUCOPHAGE, GLYBURIDE. Patient recovered.

Abraxane Side Effects Report #5049776-3
Abraxane side effect was reported by a Physician from UNITED STATES on June 22, 2006. Female patient, 63 years of age, weighting 170.9 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood glucose increased, eyelid ptosis, facial palsy, herpes simplex , neuropathy peripheral, tongue disorder. Abraxane dosage: 400 MG DAY/EVERY 3 WEEKS 8 DOSES (220 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with HORMONAL AGENTS, FENTANYL CITRATE, LIPITOR, PRILOSEC, ACCUPRIL, ZOMETA, GLUCOPHAGE, GLYBURIDE. Patient recovered.

Abraxane Side Effects Report #5988209-7
Abraxane side effect was reported by a Physician from UNITED STATES on Nov 21, 2008. Female patient, 59 years of age, weighting 269.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: abscess limb, blood glucose increased, blood pressure systolic decreased, blood urea decreased, cellulitis , culture positive, culture wound positive, heart rate increased, nausea . Abraxane dosage: 330 MG, INTRAVENOUS. During the same period patient was treated with GEMZAR, AVASTIN, FLUCONAZOLE, ESOMEPRAZOLE MAGNESIUM, ONDANSETRON, PROCHLORPERAZINE MALEATE, ACETAMINOPHEN, METFORMIN. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #5761834-4
Abraxane side effect was reported by a Physician from UNITED STATES on May 19, 2008. Female patient, 55 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alopecia, blood albumin decreased, blood glucose increased, blood sodium decreased, blood urea decreased, carbon dioxide decreased, conjunctival irritation, dermatitis, dermatitis allergic. Abraxane dosage: LAST DOSE (300 MG) PRIOR TO SAE. (120 MG/M2,WEEKLY), ,INTRAVENOUS. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5104936-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2006. Female patient, 47 years of age, weighting 112.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: abscess limb, anaemia, blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium increased, blood urea increased, dehydration, electrolyte imbalance. Abraxane dosage: 155MG X 1 DOSE (SCHEDULED EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with CARBOPLATIN, AVASTIN, NEXIUM, ADVIL, OXYCODONE. Patient was hospitalized. Patient recovered.